Daniel Menold | VP, Finance |
Sujal Shah | President, CEO & Director |
Charles McWherter | SVP & Chief Scientific Officer |
Pol Boudes | Chief Medical Officer |
Eliana Merle | Cantor Fitzgerald & Co. |
Yasmeen Rahimi | Roth Capital Partners |
Steven Seedhouse | Raymond James & Associates |
Antonio Arce | H.C. Wainwright & Co. |
June Lee | SunTrust Robinson Humphrey |
Mayank Mamtani | B. Riley FBR, Inc. |
Greetings, and welcome to the CymaBay's Therapeutics second Quarter 2019 Conference Call. [Operator Instructions].
As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Dan Menold, Vice President of Finance for CymaBay Therapeutics. Please go ahead, sir.